Form 4 Filing for Lewis H. Titterton Jr.

This filing details a transaction by Lewis H. Titterton Jr., a director at Anixa Biosciences Inc. On June 16, 2026, Titterton acquired 2,836 shares of common stock at a price of $2.64 per share. Following this transaction, Titterton directly owns 972,170 shares of Anixa Biosciences Inc. common stock. The transaction was reported on June 17, 2026, and is designated as a Form 4 filing, indicating a change in beneficial ownership.